Annual report [Section 13 and 15(d), not S-K Item 405]

Income Taxes (Tables)

v3.26.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Income Tax (Benefit)/Provision

The Company’s income tax (benefit)/provision is as follows for the years ended December 31, 2025 and 2024:

  

    2025     2024  
Current   $ -     $ -  
Deferred     (1,606,119 )     (5,446,000 )
Change in Valuation Allowance     1,606,119       5,446,000  
Income Tax Benefit   $ -     $ -  
Schedule of Components of Loss Before Income Taxes

The following table shows the components of loss before income taxes and the related income tax expense / (benefit):

    2025     2024  
Loss before income taxes                
U.S. operations   $ (11,627,122 )   $ (23,359,334 )
Current income tax expense / (benefit)                
U.S. federal     -       -  
U.S. state and local     -       -  
Total current income tax expense / (benefit)     -       -  
Deferred income tax expense / (benefit)                
U.S. federal     -       -  
U.S. state and local     -       -  
Total deferred income tax expense / (benefit)     -       -  
Total current income tax expense / (benefit)   $ -     $ -  
Schedule of Reconciliation of Income Tax Rate and Benefit from Income Taxes

The reconciliation of income taxes using the statutory U.S. income tax rate and the benefit from income taxes for the years ended December 31, 2025 and 2024 are as follows:

  

    2025     2024  
             
Statutory U.S. Federal Income Tax Rate     (21.0 )%     (21.0 )%
State income taxes, net of U.S. Federal tax effect     (7.4 )%     (7.5 )%
Adjustment to deferred tax assets     7.0 %     2.9 %
Tax credits     (2.4 )%     (1.6 )%
Non-deductible expenses     2.3 %     3.9 %
Change in Valuation Allowance     17.7 %     23.3 %
Net     0.0 %     0.0 %
Schedule of Deferred Tax Assets and Related Valuation Allowances

The principal components of the deferred tax assets and liabilities, and related valuation allowances as of December 31, 2025 and 2024 are as follows:

  

    2025     2024  
             
Reserves and other   $ 1,421,000     $ 731,000  
Net operating loss carry-forwards     29,455,000       27,869,000  
Capitalized research and development     2,513,000       3,894,000  
Research and development tax credit     2,479,000       2,205,000  
Share-based compensation     1,877,000       1,430,000  
Valuation Allowance     (37,735,000 )     (36,129,000 )
Net deferred tax asset   $ -     $ -